Skip to Content

IP 254 (Ranitidine Hydrochloride 300 mg)

Pill with imprint IP 254 is Yellow, Capsule-shape and has been identified as Ranitidine Hydrochloride 300 mg. It is supplied by Amneal Pharmaceuticals.

Ranitidine is used in the treatment of gerd; erosive esophagitis; gastric ulcer maintenance treatment; duodenal ulcer; cutaneous mastocytosis (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for IP 254

Ranitidine hydrochloride 300 mg IP 254
Ranitidine hydrochloride 300 mg IP 254
Ranitidine hydrochloride 300 mg IP 254  Front
Ranitidine hydrochloride 300 mg IP 254  Back
Ranitidine hydrochloride 300 mg IP 254
Ranitidine hydrochloride 300 mg IP 254

Ranitidine Hydrochloride

Imprint:
IP 254
Strength:
300 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Amneal Pharmaceuticals
National Drug Code (NDC):
53746-0254

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide